Transformation of LNCaP to an androgen-independent model of prostate cancer, LNCaP-19 resulted in increased cell proliferation, migration, in vivo invasive ability, and adhesion to vitronectin and fibronectin. Here, FN1 is linked to prostate carcinoma.